Modelling how the altered usage of cell entry pathways by the SARS-CoV-2 Omicron variant may affect the efficacy and synergy of TMPRSS2 and Cathepsin B/L inhibitors

Supporters

Support the authors with ResearchCoin

Tip RSC

Preprint Server

Topics

Biology

Biochemistry

Chemistry

Medicine

Microbiology

Show all topics

DOI

10.1101/2022.01.13.476267

License

CC-BY-NC-ND

Other Formats

PDF